VITEK 2

VITEK 2 is an automated system used in clinical microbiology laboratories for the rapid identification of bacteria and yeast and for performing antimicrobial susceptibility testing (AST). Developed and manufactured by the French diagnostics company bioMérieux, it represents a significant advancement in laboratory automation, enabling high-throughput, standardized analysis of clinical specimens. The system is widely adopted in hospitals and reference laboratories globally, playing a crucial role in guiding antimicrobial therapy and improving patient outcomes.

Overview

The VITEK 2 system is a fully automated, closed system platform designed to streamline workflow in the clinical laboratory. It builds upon the legacy of earlier systems like the original VITEK and the VITEK 32, incorporating advanced optical technology and sophisticated software algorithms. Its primary functions are the identification of a broad range of pathogens, including Gram-positive and Gram-negative bacteria, and the determination of minimum inhibitory concentration (MIC) values for antibiotics. The platform is integral to modern infectious disease management and supports initiatives like antimicrobial stewardship programs in institutions such as the Cleveland Clinic and Mayo Clinic.

Technology and Methodology

The core technology of VITEK 2 utilizes plastic test cards containing 64 microwells pre-loaded with various biochemical substrates or antibiotic dilutions. The system employs a dense inoculum of a pure bacterial colony suspended in a saline solution, which is automatically filled into the cards. Identification is based on colorimetric, fluorometric, and turbidimetric readings taken by an integrated optical scanner at intervals of 15 minutes. Advanced data analysis software, often integrated with laboratory information systems like Sunquest or Cerner, compares the reaction patterns against an extensive database derived from strains held at collections like the American Type Culture Collection to provide species-level identification and MIC results.

Applications in Clinical Microbiology

VITEK 2 is extensively used for identifying pathogens from critical specimens such as blood culture, urine culture, and cerebrospinal fluid. It is vital for detecting multidrug-resistant organisms like methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), and carbapenem-resistant Enterobacteriaceae (CRE). The system's AST capabilities are essential for generating antibiograms that inform empiric therapy and are used in surveillance programs by organizations like the Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO). It is also applied in food safety testing and pharmaceutical quality control.

System Components and Operation

A standard VITEK 2 configuration includes a filling module, a sealing module, an incubator-reader module, and a computer workstation running the bioMérieux software. The cassette-based loading system allows for continuous, random-access operation. Operation involves preparing a McFarland standard suspension of the isolate, which is then placed into the filling station. The system automates card filling, sealing, incubation, and reading. The incubator maintains a constant temperature, and the optical system monitors reactions. Results are typically available within 4 to 18 hours, a significant improvement over traditional manual methods like the API test or Kirby-Bauer disk diffusion.

Advantages and Limitations

Key advantages include a significant reduction in turnaround time compared to conventional methods, high reproducibility, reduced manual labor, and advanced data management capabilities that support epidemiological tracking. However, limitations exist. The system requires a significant initial capital investment and ongoing costs for disposable cards. Some fastidious or rare organisms, such as certain anaerobic bacteria or Corynebacterium species, may not be reliably identified and may require confirmation with matrix-assisted laser desorption/ionization (MALDI-TOF) or 16S ribosomal RNA sequencing. Occasional errors in identification or AST can occur, necessitating technologist review.

Comparison with Other Identification Systems

VITEK 2 is a major competitor in the automated microbiology market alongside systems like the BD Phoenix from Becton Dickinson and the MicroScan WalkAway from Beckman Coulter. Compared to these, VITEK 2 is often noted for its high degree of automation and user-friendly interface. The emerging gold standard for microbial identification, MALDI-TOF technology (exemplified by the Bruker MALDI Biotyper and the VITEK MS from bioMérieux), provides even faster identification but typically does not perform AST. Therefore, VITEK 2 and similar systems remain essential for comprehensive phenotypic susceptibility profiling, often working in tandem with genotypic methods like polymerase chain reaction (PCR) for detecting specific resistance genes.